MIMETAS, in a consortium with Radboudumc and FHNW, has received 1.6 million USD funding for development of a kidney-on-a-chip for toxicological applications. A panel of experts from GlaxoSmithKline, Pfizer, Roche, NC3Rs and renowned academic institutions selected MIMETAS’ solution from a strong line-up of competing technologies.
As Miriam Luizink’s successor, Roy Kolkman will take up his new position as Director of High Tech Factory on 1 July 2014. Roy had already taken over Miriam’s directorship of High Tech Facilities, a High Tech Factory subsidiary, in January 2014.
In keeping with its enhanced ambitions regarding entrepreneurship in the new strategy, the University of Twente (UT) is moving rapidly to broaden and strengthen cooperation between the university and industry. To achieve this goal, the Executive Board has appointed a Director of Strategic Business Development who will coordinate matters and provide the driving force required. For the next few years, this post will be held by ir. Miriam Luizink.